Valion Bio interim CEO awarded 50,000 stock units

One fourth of the award is scheduled to vest quarterly, beginning December 22, 2026.

Rhea-AI Filing Summary

Valion Bio, Inc. (symbol: VBIO) is the issuer of record for a Form 4 filing submitted to the SEC. Zikria Dean reported acquisition or exercise transactions in this Form 4 filing.

Valion Bio, Inc. (VBIO) Interim CEO and director Zikria Dean received an award of 50,000 restricted stock units on September 22, 2026. Each unit is convertible into one common share, and one fourth is scheduled to vest quarterly, beginning December 22, 2026. The reported amounts reflect the company’s 1-for-25 reverse stock split on August 31, 2026; Dean’s reported direct RSU holdings following the award were 50,000 units.

Insider Trade Summary

Grant/Award: 50,000 shares

Grant/Award 1 txn

Insider Zikria Dean

Role Interim CEO

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units F1, F2, F3	50,000	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 50,000 contracts (Direct)

Footnotes (3)

1. F1. Each Restricted Stock Unit is convertible into one share of Common Stock.
2. F2. One fourth (1/4) of the Restricted Stock Units shall vest quarterly, with the first vesting occurring on December 22, 2026.
3. F3. These numbers have been adjusted to reflect the reverse stock split of the common stock of Valion Bio, Inc., which underwent a reverse stock split at a ratio of 1-for-25 on August 31, 2026.

Key Figures

Restricted stock units awarded: 50,000 units Underlying Common Stock: 50,000 shares Quarterly vesting portion: One fourth of the restricted stock units +1 more

4 metrics

Restricted stock units awarded 50,000 units Awarded September 22, 2026

Underlying Common Stock 50,000 shares Each restricted stock unit is convertible into one share

Quarterly vesting portion One fourth of the restricted stock units First vesting scheduled for December 22, 2026

Reverse stock split 1-for-25 Valion Bio common stock split on August 31, 2026; reported amounts reflect the split

Key Terms

Restricted Stock Unit, vest, reverse stock split

3 terms

Restricted Stock Unit financial

"Each Restricted Stock Unit is convertible into one share of Common Stock."

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

vest financial

"One fourth (1/4) of the Restricted Stock Units shall vest quarterly"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

reverse stock split financial

"underwent a reverse stock split at a ratio of 1-for-25"

A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many restricted stock units did VBIO Interim CEO Zikria Dean receive?

Zikria Dean received an award of 50,000 restricted stock units on September 22, 2026. The reported direct RSU holdings following the award were 50,000 units.

Was Zikria Dean’s VBIO RSU award under a Rule 10b5-1 plan?

No Rule 10b5-1 plan is reported for the award.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/24/2026 - 04:47 PM Accepted by SEC EDGAR 09/24/2026 - 04:46 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zikria Dean

(Last) (First) (Middle)

1305 E. HOUSTON ST., BLDG 1, STE. 311

(Street)

SAN ANTONIO TEXAS 78205

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Valion Bio, Inc. [ VBIO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Interim CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	09/22/2026		A		50,000		(2)	(2)	Common Stock	50,000	$0	50,000(3)	D

Explanation of Responses:

1. Each Restricted Stock Unit is convertible into one share of Common Stock.

2. One fourth (1/4) of the Restricted Stock Units shall vest quarterly, with the first vesting occurring on December 22, 2026.

3. These numbers have been adjusted to reflect the reverse stock split of the common stock of Valion Bio, Inc., which underwent a reverse stock split at a ratio of 1-for-25 on August 31, 2026.

	/s/ Dean Zikria	09/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)